Tag: johnson&johnson

February 17, 2017 Off

Risperdal gynecomastia lawsuits move forward, as Pennsylvania mass tort program schedules March meeting

By Dino Mustafić

Risperdal lawsuits involving Johnson & Johnson medication to gynecomastia, (male breast growth) and other side effects allegedly associated with use of the atypical antipsychotic medication continue to move forward in the Philadelphia Court of Common Pleas, said Bernstein Liebhard LLP is a New York-based law firm representing the victims of defective drugs and medical devices in USA.